SAMchain technology: how to own your own genes

Category: Blockchain Med Tech
Posted by
Ravindu Dabarera

According to research published in the Genome Biology journal just yesterday, leading genetic researchers and professors have pioneered a new way of securing and enabling ownership of genomic data in the digital age; putting it on the Blockchain through SAMchain technology.

Owning your own blueprint: SAMchain Technology

Mark Gerstein, the Professor of Biomedical Informatics at Albert L. Williams, whose remit also covers molecular biophysics, biochemistry, computer science, statistics and data science , stated that the intention behind the initiative was to spearhead the next generation of genetic data ownership.

“Our primary goal is to give ownership of genomic data back to the individual. As genomic data becomes increasingly integral to our understanding of human health and disease, its integrity and security must be a priority when providing solutions to storage and analysis.”

While this honorable goal may seem quite abstract to the layman, the truth is that data ownership is becoming an ever more vital aspect of identity and individual sovereignty as society becomes more data-based. Millions of people have already yielded ownership of their genetic data to private companies under the pretense of ancestry discovery or medical risk inquiry.

Beyond ownership: Protecting data integrity

SAMchain, as the technology has been dubbed, encodes individual genomic information and transfers its ownership to the individual. Beyond its role in data ownership, the non-editable of information stored on the Blockchain also has a vital benefit in ensuring that the data remains uncorrupted.

“Corruption, change, or loss of personal genomes could create problems in patient care and research integrity in the future.”

This innovation also helps pave the path towards genuinely personalized medicine. By allowing patients to directly provide their doctors with a store of their genetic data, medical professionals may have a better hand in developing bespoke treatments. This could also lead to a monetization of data with pharmaceutical companies paying to gain access to genetic information.

The Yale team was also led by Gamze Gürsoy, a Core Faculty Member at the New York Genome Center, and Charlotte Brannon, a PhD student at Stanford University studying cell, molecular, and organismal biology.

Information sourced from YaleNews.

Join us in Belgrade, Serbia from the 22-25th August:

With the peninsula being known for its natural beauty, rich cultural landscape and fantastic delicacies, the Balkans are renowned for having some of the most quintessentially Mediterranean vistas and experiences. From the Adriatic coastline of Split to the fairytale-esque castle of Lake Bled, the region has a lot to offer the world. This being said, something that fewer may know is the fact that the nations of the Balkans are incubating a nascent but powerfully growing technical expertise when it comes to frontier technology such as Blockchain, AI and more. Therefore the region may not only be a rich adventure into the past but my also serve as a window into the very near future.

Join us in Belgrade for the best the industry has to offer and for a window into the future of Deep Tech. To learn more about sponsorship and speaking opportunities or to inquire about attending the event, please contact Sophie at [email protected]